Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy

NCT02920021 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Peanut Allergy

Interventions

DRUG: Etokimab
DRUG: Placebo

Sponsor

AnaptysBio, Inc.